Among patients with gout in the US, Black individuals and those living in the South were associated with reduced adherence to allopurinol.

The current strategy for managing chronic gout is the use of uric-acid-lowering drugs to reduce urate production or of a uricosuric agent to promote renal uric acid excretion. Probenecid is ...

According to the NHS the main symptoms of gout are sudden severe pain in a joint – usually your big toe, but it can be in ...

Uric acid crystals can accumulate under the skin and form lumps called "tophi." Chronic (long-term) gout can cause knee ...

The third phase, inter-critical gout, is a period between acute attacks when the patient is symptom-free. Finally, chronic ...

Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate (sUA) levels, ...

Gout is a disease characterized by recurrent attacks of arthritis, in which uric acid appears in excessive amounts in the ...

Gout is a type of inflammatory arthritis that causes joint pain and swelling, usually as flares that last for a week or two ...

Summary. Febuxostat is a novel non-purine selective inhibitor of xanthine oxidase for the management of hyperuricemia in patients with gout. The ability of febuxostat to decrease serum uric acid ...